Article | Development, Government & Politics, Health, Inequality & Distribution, Technology & Innovation
Transforming Corporate Governance to Improve Access to Medicines in the Global South
Affordable medicines remain out of reach for millions because pharmaceutical innovation is organized around value extraction, not public health. How do shareholder-driven governance and fragmented global health financing reinforce inequity, and what structural reforms are needed to reverse it?
By Padmashree Gehl Sampath, Öner Tulum, and William Lazonick